Download PDF

Other users also viewed these articles

FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease Mário Reis Álvares-da-Silva; Márcia da Silva Vargas; Soheyla Mohd Souza Rabie; Gabriella Jonko; Patricia Gabriela Riedel; Larisse Longo; Marcelo Rodrigues Gonçalves; Vivian Cristine Luft; Dvora Joveleviths;
10.1016/j.aohep.2024.101584
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis Shudi Li; Fei Duan; Suling Li; Baoping Lu;
Ann Hepatol. 2024;29: